Irrespective of the actual mechanism, the reduced overall survival in pancreatic ductal adenocarcinoma patients with low C/EBPδ levels might be directly linked to the increased lymph node metastases in these patients. The gene discussed is CEBPD; the disease is pancreatic ductal adenocarcinoma.